Reports- Onychomycosis (Tinea Unguium) Drug Market

Global Onychomycosis (Tinea Unguium) Drug
Market by Manufacturers, Countries, Type and
Application, Forecast to 2022
No of Pages – 115
Publishing Date - April 3, 2017
Browse detailed TOC, Tables, Figures, Charts in Global Onychomycosis (Tinea Unguium)
Drug Market by Manufacturers, Countries, Type and Application, Forecast to 2022 at -
http://www.360marketupdates.com/10561772
"Onychomycosis is a fungal infection of the toenails or fingernails that may involve any component
of the nail unit, including the matrix, bed, or plate.
Onychomycosis (Tinea Unguium) Drug is the drug for the treatment of the disease."
Scope of the Report:
This report focuses on the Onychomycosis (Tinea Unguium) Drug in Global market, especially in
North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report
categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Johnson & Johnson
GSK
Novartis
Pfizer
Valeant Pharma
Kaken Pharmaceutical
Galderma
Xiuzheng Pharmaceutical
Letai
Qilu Pharmaceutical
Market Segment by Regions, regional analysis covers
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Columbia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Oral
External
Market Segment by Applications, can be divided into